Biocept, Inc. BIOC
Set alert
0.43 0.00 0.00%
At close · Jan 16
0.4349 Day range 0.4901
52-week range unavailable
- Open
- 0.4901
- Prev close
- 0.4349
- Mkt cap
- 450.79K
- Vol
- 572.52K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.4349
- High
- 0.4901
- Forward P/E
- 0.00
- Beta
- 0.00
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 20, 2023
- 50-d avg
- 0.00
- 200-d avg
- 0.00
3M chart
Signals (17)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 24, 2023 | 3 years ago |
| RSI: Overbought | Oct 19, 2023 | 3 years ago |
| SMA: Bullish | Oct 16, 2023 | 3 years ago |
| SMA: Bullish | Oct 16, 2023 | 3 years ago |
| MACD: Buy Signal | Oct 16, 2023 | 3 years ago |
| SMA: Bearish | Oct 2, 2023 | 3 years ago |
| SMA: Bearish | Oct 2, 2023 | 3 years ago |
| MACD: Sell Signal | Sep 28, 2023 | 3 years ago |
| RSI: Overbought | Sep 15, 2023 | 3 years ago |
| SMA: Bullish | Sep 8, 2023 | 3 years ago |
| SMA: Bullish | Sep 8, 2023 | 3 years ago |
| RSI: Oversold | Sep 5, 2023 | 3 years ago |
| RSI: Oversold | Aug 31, 2023 | 3 years ago |
| RSI: Oversold | Aug 16, 2023 | 3 years ago |
| SMA: Bearish | Jul 27, 2023 | 3 years ago |
| SMA: Bullish | Jul 26, 2023 | 3 years ago |
| SMA: Bearish | Jul 25, 2023 | 3 years ago |
Key statistics
- Market cap
- 0
- Trailing P/E
- 0.00
- Forward P/E
- 0.00
- Price / sales
- 0.00
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- 50-day average
- 0.00
- 200-day average
- 0.00
Next earnings
Nov 20, 2023
Expected Nov 20, 2023. Consensus EPS estimate 0.00.
Financials — quick view
BIOC Revenue — quarterly 589.00K
BIOC Net income — quarterly -3.63M
BIOC EPS — quarterly -3.50
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 20, 2023 | Sep 1, 2023 | 0.00 | — | — | — |
| May 10, 2023 | Mar 1, 2023 | 0.00 | — | — | — |
| Apr 17, 2023 | Dec 1, 2022 | 0.00 | — | — | — |
| Nov 21, 2022 | Sep 1, 2022 | -4.80 | — | — | — |
| Nov 10, 2022 | Jun 1, 2022 | 0.00 | — | — | — |
| May 23, 2022 | Mar 1, 2022 | -7.21 | — | — | — |
News
- Why EngageSmart Shares Are Trading Higher By Around 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session
- 12 Health Care Stocks Moving In Friday's Pre-Market Session
- Why Nokia Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
- Why Netflix Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
- Why Nuvve Holding Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
- 12 Health Care Stocks Moving In Wednesday's Intraday Session
- Why Talaris Therapeutics Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
- Enrollment Completed in the Feasibility Phase of the FORESEE Clinical Trial with Biocept's CNSide™ Assay to Evaluate Patients with Leptomeningeal Metastases
- Biocept Signs CNSide™ Licensing Agreement with Plus Therapeutics
- Biocept to Participate in the H.C. Wainwright Global Investment Conference
Your note
Sign in to keep a note on BIOC — it syncs with the Stock Master app.